May 09, 2019
Neovasc Announces First Quarter 2019 Financial Results
Apr 25, 2019
ReWalk Announces Regional Blue Cross Blue Shield Plan Beneficiaries Are Winning Requests to Walk Again
Apr 18, 2019
Hyperblock Inc. Announces Delay of Annual Filings, Additions and Changes to Board of Directors, and Transition of Interim Chief Financial Officer
Apr 17, 2019
Neovasc Announces Resolution of Last Remaining Active Litigation
Apr 16, 2019
ReWalk Announces First Personal Exoskeleton Provided to Cigna Beneficiary
Feb 22, 2019
Neovasc Announces Refiling of Interim Financial Statements and Management's Discussion and Analysis for the Period Ended September 30, 2018
Feb 11, 2019
EnSync Energy Systems announces Board Departures and State of Business
Jan 22, 2019
Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
Jul 30, 2018
BioAmber Provides Update on Sales Process
Jul 25, 2018
Egalet to Host Conference Call and Webcast to Discuss Second Quarter 2018 Financial Results on August 8, 2018
Jun 29, 2018
The ExOne Company Announces Global Cost Realignment
May 04, 2018
BioAmber Announces Filing for Stay of Proceedings on Creditors
Apr 02, 2018
ReShape Lifesciences Announces Fourth Quarter and Year End 2017 Financial Results
Apr 02, 2018
Pareteum's Audit Opinion Removes Going Concern Explanation
Mar 26, 2018
ImmunoCellular Therapeutics Receives Audit Opinion with Going Concern Explanation
Mar 15, 2018
BioAmber Delays Filing of Annual Report on Form 10-K and Postpones Earnings Release and Conference Call for Fourth Quarter and Full Year 2017
Nov 30, 2017
ICYMI: ReWalk's Restore technology for stroke patients featured in MD&DI
Nov 30, 2017
Correcting and Updating: ReWalk's Restore technology for stroke patients featured in MD&DI
Nov 20, 2017
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Nine Months Ended September 30, 2017
Nov 15, 2017
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended June 30, 2017